The Face of Longevity.

Sonscreen is a biotechnological defense system that redefines sun protection as the ultimate frontier of longevity science. Where conventional sunscreen merely blocks ultraviolet rays, Sonscreen masters light itself — deploying a translucent mesh of liquid particles that shields the architectural structure of every skin cell and transforms photonic damage into preserved radiance.

The platform is built for those who treat their skin as infrastructure: longevity clinicians, dermatological researchers, and individuals who view their complexion as a sacred biological canvas to be defended across decades. Each formulation in the Sonscreen collection — from the Aurora Veil daily serum to the Solar Monolith maximum-defense concentrate — is accompanied by a Bio-Signature documenting its cellular benefits, its defense spectrum across UV-A, UV-B, blue light and infrared, and the molecular origins of every active ingredient.

Sonscreen is developed and managed by John D Abravanel Berdugo, CEO and Founder of U.S. Longevity Laboratories, Inc. — a research-driven organization devoted to engineering the intersection of photonic science and human longevity. The laboratory operates at the convergence of sterile biotech precision and high-fashion opulence, advancing a single mission: to preserve the future of human radiance for generations to come.